MLICM
ADNT icon

Metropolitan Life Insurance Company (MetLife)’s Adient ADNT Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ADNT Stock Details ADNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,816
Closed -$159K – 48
2024
Q1 		$159K Sell
4,816
-488
-9% -$16.6K 0.01% 807
2023
Q4 		$193K Sell
5,304
-198
-4% -$6.8K 0.01% 745
2023
Q3 		$202K Buy
5,502
+292
+6% +$11.6K 0.01% 671
2023
Q2 		$200K Buy
+5,210
New +$193K 0.01% 681
2023
Q1 		– Sell
-5,847
Closed -$203K – 2309
2022
Q4 		$203K Buy
5,847
+223
+4% +$7.8K 0.01% 709
2022
Q3 		$156K Hold
5,624
– – 0.01% 775
2022
Q2 		$167K Sell
5,624
-354
-6% -$11.9K 0.01% 789
2022
Q1 		$244K Sell
5,978
-33,715
-85% -$1.45M 0.01% 727
2021
Q4 		$1.9M Sell
39,693
-682
-2% -$30.6K 0.03% 562
2021
Q3 		$1.67M Buy
+40,375
New +$1.61M 0.02% 609
2021
Q2 		– Sell
-40,945
Closed -$1.81M – 2710
2021
Q1 		$1.81M Buy
40,945
+1,145
+3% +$43.2K 0.03% 565
2020
Q4 		$1.38M Sell
39,800
-935
-2% -$26.4K 0.02% 670
2020
Q3 		$706K Sell
40,735
-2,442
-6% -$42.6K 0.01% 957
2020
Q2 		$709K Sell
43,177
-5,724
-12% -$87K 0.01% 967
2020
Q1 		$444K Sell
48,901
-1,258
-3% -$25.3K 0.01% 1116
2019
Q4 		$1.07M Sell
50,159
-464
-0.9% -$10.3K 0.02% 859
2019
Q3 		$1.16M Buy
50,623
+25,596
+102% +$584K 0.02% 780
2019
Q2 		$607K Buy
25,027
+6
+0% +$123 0.01% 1179
2019
Q1 		$324K Buy
+25,021
New +$438K 0.01% 1579

Other funds holding ADNT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ADNT Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Adient (ADNT) in Q2 2024, closing a stake of 4,816 shares — an estimated $159K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ADNT in Q1 2019 and held it in 19 quarters. The position peaked at $1.9M in Q4 2021. 279 funds tracked by Wall St. Rank hold ADNT as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Adient position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 4,816 Adient shares in Q2 2024, an estimated $159K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Adient in Q1 2019 and held it in 19 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Adient position peaked at $1.9M in Q4 2021.
  • 279 funds tracked by Wall St. Rank held Adient as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.